• Home
  •  / Tactile Medical

Tactile Medical

OverviewSuggest Edit

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. The Company's offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinicians.

TypePublic
Founded2006
HQMinneapolis, MN, USMap
Websitetactilemedical.com
Employee Ratings3.8More
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)629(+27%)
Revenue (FY, 2019)$189.5 M(+32%)
Share Price (Jan 2021)$52
Cybersecurity ratingBMore

Key People/Management at Tactile Medical

Daniel L. Reuvers

Daniel L. Reuvers

President, Chief Executive Officer and Director
Bryan F. Rishe

Bryan F. Rishe

Senior Vice President, Sales
Mary M. Thompson

Mary M. Thompson

Vice President, Payer Initiatives
Thomas F. O'Donnell

Thomas F. O'Donnell

Chief Medical Officer
R. Jay Stracke

R. Jay Stracke

Vice President of Reimbursement and Payer Relations
Darren J. Wennen

Darren J. Wennen

Vice President, Marketing and Clinical Affairs
Show more

Tactile Medical Office Locations

Tactile Medical has an office in Minneapolis
Minneapolis, MN, US (HQ)
1331 Tyler St NE #200
Minneapolis, MN, US
3701 Wayzata Blvd #300
Show all (2)

Tactile Medical Financials and Metrics

Tactile Medical Revenue

Embed Graph
View revenue for all periods
Tactile Medical's revenue was reported to be $189.49 m in FY, 2019
USD

Revenue (Q3, 2020)

49.1m

Gross profit (Q3, 2020)

35.0m

Gross profit margin (Q3, 2020), %

71.2%

Net income (Q3, 2020)

2.4m

EBIT (Q3, 2020)

1.8m

Market capitalization (20-Jan-2021)

1.0b

Closing stock price (20-Jan-2021)

52.0

Cash (30-Sept-2020)

42.2m

EV

990.6m
Tactile Medical's current market capitalization is $1 b.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

84.5m109.3m143.8m189.5m

Cost of goods sold

22.9m29.0m41.5m55.3m

Gross profit

61.6m80.3m102.3m134.2m

Gross profit Margin, %

73%73%71%71%
Quarterly
USDQ2, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

19.7m19.9m26.3m28.3m26.8m34.1m36.3m37.6m45.2m49.6m43.7m35.1m49.1m

Cost of goods sold

5.3m5.6m7.0m7.5m7.3m9.6m10.1m11.4m13.7m14.2m12.6m10.2m14.1m

Gross profit

14.4m14.2m19.2m20.8m19.5m24.5m26.2m26.3m31.5m35.4m31.1m24.9m35.0m

Gross profit Margin, %

73%72%73%73%73%72%72%70%70%71%71%71%71%
show all
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

30.7m24.0m20.1m22.8m

Accounts Receivable

15.0m17.6m24.3m33.4m

Prepaid Expenses

981.0k2.2m1.8m2.5m

Inventories

6.6m11.0m11.2m19.1m
Quarterly
USDQ2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

6.7m39.3m20.7m18.1m19.7m25.3m17.3m23.1m23.5m25.0m19.8m32.3m31.3m42.2m

Accounts Receivable

12.6m13.0m11.4m12.9m14.6m14.2m17.5m20.2m21.7m24.8m27.7m30.8m30.6m36.0m

Prepaid Expenses

434.0k808.0k870.0k708.0k932.0k1.1m947.0k2.4m1.7m1.6m2.0m2.0m2.2m4.0m

Inventories

5.9m6.2m6.9m9.6m9.8m14.7m16.4m14.9m11.3m13.2m16.9m22.4m24.8m22.4m
show all
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

2.9m5.9m6.6m11.0m

Depreciation and Amortization

799.0k1.8m3.6m3.5m

Inventories

(773.0k)(4.5m)(870.0k)(7.9m)

Accounts Payable

1.7m462.0k690.0k(1.4m)
Quarterly
USDQ2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

8.0k500.0k(1.5m)2.3m3.6m(50.0k)2.5m4.3m1.5m4.3m6.7m(1.3m)(15.2m)(12.7m)

Depreciation and Amortization

437.0k675.0k398.0k664.0k1.1m563.0k1.7m2.5m996.0k1.8m2.6m730.0k1.5m2.1m

Inventories

(164.0k)(467.0k)(379.0k)(3.1m)(3.8m)(3.6m)(5.4m)(3.9m)(132.0k)(2.0m)(5.7m)(3.3m)(5.9m)(3.5m)

Accounts Payable

1.0m1.7m(394.0k)1.3m370.0k885.0k309.0k(508.0k)722.0k1.6m979.0k4.7m1.6m938.0k
show all
USDQ2, 2016

Revenue/Employee

84.2k

Financial Leverage

-5.7 x
Show all financial metrics

Tactile Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

Learn more about our premium products
SecurityScorecard logo

Tactile Medical Online and Social Media Presence

Tactile Medical's Trends

Embed Graph

Tactile Medical News and Updates

January 05, 2021

Tactile Medical Announces Additions to Board of Directors

Appointment of Sheri Dodd and Deepti Jain Appointment of Sheri Dodd and Deepti Jain
January 05, 2021

Tactile Medical to Present at the ICR Conference 2021

MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in a fireside chat …
October 01, 2020

Tactile Medical to Release Third Quarter of Fiscal Year 2020 Financial Results on November 2, 2020

MINNEAPOLIS, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that third quarter of fiscal year 2020 financial resu…
February 24, 2020

Tactile Medical Announces Update to Qui Tam Complaint

MINNEAPOLIS, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, announced today that the Company’s motion to dismiss the qui tam com…
July 01, 2019

Tactile Medical to Release Second Quarter of Fiscal Year 2019 Financial Results on August 5, 2019

MINNEAPOLIS, July 01, 2019 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that second quarter of fiscal year 2019 financial res…
May 15, 2019

Tactile Medical to Present at the William Blair 39th Annual Growth Stock Conference

MINNEAPOLIS, May 15, 2019 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the William Blair…
Show more

Tactile Medical Blogs

November 03, 2020

Tactile Medical to Participate in Upcoming Investor Conferences in November and December

MINNEAPOLIS , Nov. 03, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the following
September 01, 2020

Tactile Medical to Participate in Two Upcoming Investor Conferences in September

MINNEAPOLIS , Sept. 01, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the following
August 05, 2020

Tactile Medical to Present at the Canaccord Genuity 40th Annual Global Growth Conference

Tactile Medical to Present at the Canaccord Genuity 40th Annual Global Growth Conference Content Import Wed, 08/05/2020 - 16:07 Tactile Medical to Present at the Canaccord Genuity 40th Annual Global Growth Conference August 5, 2020 at 4:05 PM EDT This release …
August 03, 2020

Tactile Systems Technology, Inc. Reports Second Quarter 2020 Financial Results

Second Quarter Revenue Decreased 22% Year-Over-Year; Decreased 20% Year-Over-Year on an Operational Basis First Half Revenue Decreased 5% Year-over-Year; Flat Year-over-Year on an Operational Basis MINNEAPOLIS , Aug. 03, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc.
May 21, 2020

Tactile Systems Technology, Inc. Announces Appointment of Daniel L. Reuvers as President and Chief Executive Officer

MINNEAPOLIS , May 21, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that Daniel L.
May 04, 2020

Tactile Systems Technology, Inc. Reports First Quarter 2020 Financial Results

Tactile Systems Technology, Inc. Reports First Quarter 2020 Financial Results Content Import Mon, 05/04/2020 - 07:01 Tactile Systems Technology, Inc. Reports First Quarter 2020 Financial Results May 4, 2020 at 7:00 AM EDT This release is a backfill from a News…
Show more

 Tactile Medical Frequently Asked Questions

  • When was Tactile Medical founded?

    Tactile Medical was founded in 2006.

  • Who are Tactile Medical key executives?

    Tactile Medical's key executives are Daniel L. Reuvers, Bryan F. Rishe and Mary M. Thompson.

  • How many employees does Tactile Medical have?

    Tactile Medical has 629 employees.

  • What is Tactile Medical revenue?

    Latest Tactile Medical annual revenue is $189.5 m.

  • What is Tactile Medical revenue per employee?

    Latest Tactile Medical revenue per employee is $301.3 k.

  • Who are Tactile Medical competitors?

    Competitors of Tactile Medical include EBT Medical, GAIA and SinuSys.

  • Where is Tactile Medical headquarters?

    Tactile Medical headquarters is located at 1331 Tyler St NE #200, Minneapolis.

  • Where are Tactile Medical offices?

    Tactile Medical has an office in Minneapolis.

  • How many offices does Tactile Medical have?

    Tactile Medical has 2 offices.